The allergic March from Staphylococcus aureus superantigens to immunoglobulin E

Chemical Immunology and Allergy

Volumn 93, Issue 1, 2007, Pages 106-136

  Gould, Hannah J ^a   Takhar, Pooja ^a   Harries, Helen E ^a   Chevretton, Elfy ^b   Sutton, Brian J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; B LYMPHOCYTE RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PREDNISOLONE; STAPHYLOCOCCUS ENTEROTOXIN; STEROID; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLERGY; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL FLORA; BACTERIAL INFECTION; BASOPHIL; CELL ACTIVATION; CELL ACTIVITY; COMMENSALISM; GENE REARRANGEMENT; HOST; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT MUCOSA; RHINITIS; SENSITIZATION; SKIN INFECTION; SOMATIC HYPERMUTATION; STAPHYLOCOCCUS AUREUS; SYMBIOSIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; HYPERSENSITIVITY; IMMUNOLOGY; REVIEW;

ALLERGENS; ANIMALS; ASTHMA; B-LYMPHOCYTES; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN E; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 34249728822     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000100861     Document Type: Article

References (119)

1. Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, McCloskey N, Coker HA, Fear D, Smurthwaite L: The biology of IgE and the basis of allergic disease. Annu Rev Immunol 2003;21:579-628.
2. Gould HJ, Takhar P, Harries HE, Durham SR, Corrigan CJ: Germinal-centre reactions in allergic inflammation. Trends Immunol 2006;27:446-452.
3. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P: The Vg-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989;56:27-35.
4. Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science 1990;248: 705-711.
5. Kotzin BL, Leung DY, Kappler J, Marrack P: Superantigens and their potential role in human disease. Adv Immunol 1993;54:99-166.
6. Goodyear CS, SilAerman GJ: B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies. Springer Semin Immunopathol 2005;26:463-484.
7. Viau M, Zouali M: B lymphocytes, innate immunity and autoimmunity. Clin Immunol 2005;114: 17-26.
8. Silverman GJ, Goodyear LS: Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat Rev Immunol 2006;56:465-475.
9. Proft T, Fraser JD: Bacterial superantigens. Clin Exp Immunol 2003;133:299-306
10. Leung DYM: AtTpic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-319.
11. Breuer K, Kapp A, Werfel T: Bacterial infections and atopic dermatitis. Allergy 2001;56: 1034-1041.
12. Leyden JJ, Marples RR, Kligman AM: Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-530.
13. Bunikowski R, Mielke M, Skarabis H, Worm M, Anagnostopoulos I, Kilde G, Wahn U, Renz H: Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000;105:814-819.
14. McFadden JP, Noble WC, Camp RD: Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993;128:631-632.
15. Lever R, Hadley K, Downey D, Mackie R: Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189-198.
16. Hauk PJ, LeungNDY: Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? J Allergy Clin Immunol 2001;107:391-392.
17. Bachert C, Gevaert P, van Cauwenberge P: Staphlococcus aureus entertoxins: A key in airway disease? Allergy 2002;57:480-487.
18. Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-520.
19. Beasley R, Crane J, Lai CKW, Pearce N: Prevalence and etiology of asthma. J Allergy Clin Immunol 2000;105:S466-S472.
20. Shiomori T, Yoshida S, Miyamoto H, Makishima K: Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis. J Allergy Clin Immunol 2000;105: 449-454.
21. Riechelmann H, Essig A, Duetschle T, Rau A, Rothermel B, Weschta M: Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls. Allergy 2005;60: 1418-1423.
22. Bachert C, Gevaert P, Howarth P, Holtappels G, van Cauwenberge P, Johansson SGO: IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol 2003;111:1131-1132.
23. Rosso RE, Monasterolo G: Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SEA, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol 2004;133:261-266.
24. Van Zele T, Gevaert P, Watelet J-B, Claeys G, Holtappels G, Claaeys C, van Cauwenberge P, Bachert C: Staphyloccus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004;114:981-983.
25. Johnston SL: Macrolide antibiotics and asthma treatment. J Allergy Clin Immunol 2006;117: 1233-1236.
26. Janeway JA Jr, Travers P, Walport M, Schlomchik MJ: Immunobiology, ed 6, revised. New York, Garland Science, 2005.
27. Mourad W, Scholl P, Diaz A, Geha R, Chatila T: The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction. J Exp Med 1989;170:2011-2022.
28. Petersson K, Hakansson M, Nilsson H, Forsberg G, Svensson LA, Liljas A, Walse B: Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence. EMBO J 2001;20:3306-3312.
29. Fields BA, Malchiodi EL, Li H, Ysern X, Stauffacher CV, Schlievert PM, Karjalainen K, Mariuzza RA: Crystal structure of a T-cell receptor β-chain complexed with a superantigen. Nature 1996;384: 188-192.
30. Alouf JE, Müller-Alouf H: Staphylococcal and streptococcal superantigens: Molecular, biological and clinical aspects. Int J Med Microbiol 2003:292:429-440.
31. Baker MD,SAcharya KR: Superantigens: structure-function relationships. Int J Med Microbiol 2004;293:529-537.
32. Coker HA, Durham SR, Gould HJ: Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 2003;171:5602-5610.
33. Petersen-Mahrt S: DNA deamination in immunity. Immunol Rev 2005;203:80-97.
34. Selsing E: Ig Tlass switching: targeting the recombinational mechanism. Curr Opin Immnol 2006; 18:249-254.
35. Pascual V, Capra JD: B-cell superantigens? Curr Biol 1991;1:315-317.
36. Silverman GJ, Goodyear CS: A model B-cell superantigen and the immunobiology of B lymphocytes. Clin Immunol 2002;102:117-134.
37. Zouali M: B-cellIsuperantigens: implications for selection of the human antibody repertoire. Immunol Today 1995;16:399-405.
38. Cook GP, Tomlinson IM: The human immunoglobulin VH repertoire. Immunol Today 1995;16: 237-242.
39. Brezinschek H-P, Brezinschek RI, Lipsky PE: Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995;155:190-202.
40. Graille M, Stura EA, Corper AL, Sutton BJ, Taussig MJ, Charbonnier JB, Silverman GJ: Crystal structure of a Staphyloccus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 2000;97:5399-5404.
41. Silverstein AM, Rose NR: On the implications of polyclonal B cell activation. Nat Immunol 2003;4: 931-932.
42. Hauser C, Wuethrich B, Matter L, Wilhelm JA, Sonnabend W, Schopfer K: Staphyloccus aureus skin colonization in atopic dermatitis patients. Dermatologica 1985;170:35-309.
43. Leung DYM: Infection in atopic dermatitis. Curr Opin Pediatr 2003;15:399-404.
44. Domiati-Saad R, Lipsky PE: Staphylococcal enterotoxin A induces survival of VH3-expressing human B cells by binding to the VH region with low affinity. J Immunol 1998;161:1257-1266.
45. Domiati-Saad R, Attrep JF, Brezinschek H-P, Cherrie AH, Karp DR, Lipsky PE: Staphylococcal enterotoxin D functions as a human B cell superantigen by rescuing VH4-expressing B cells from apoptosis. J Immunol 1996;156:3608-3620.
46. Del Prete G: The concept of type 1 and type 2 helper T cells and their cytokines in humans. Int Rev Immunol 1998;16:427-455.
47. Romagnani S, Del Prete G: How T cells direct IgE switching; in Vercelli D (ed): IgE Regulation: Molecular Mechanisms. Chichester, Wiley, 1997, pp 1-20.
48. Gould HJ, Beavil RL, Eercelli D: IgE isotype determination: epsilon germline gene transcription, DNA recombination and B cell differentiation. Br Med Bull 2000;56:908-924.
49. Tangye SG, Ferguson A., Avery DT, Ma CS, Hodgkin PD: Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol 2002;169:4298-4306.
50. Muramatsu M, Kinoshita K, Fagarasan S, Yamada Y, Shinkai Y, Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000;102:553-563.
51. Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung DYM: Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: A potential role in the modulation of IgE synthesis. J Immunol 1998;160:4622-4627.
52. Hofer MF, Jirapongsananuruk O, Truble AE, Leung DY: Upregulation of B7.2 but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998;101:96-101.
53. Von Schwedler V, Jack HM, Wabl M: Circular DNA is a product of the immunoglobulin class switch rearrangement. Nature 1990;345:452-456.
54. Kinoshita K, Harigai M, Fagarasan S, Muramatsu M, Honjo T: A hallmark of active class switch recombination: Transcripts directed by I promoters on looped-out circular DNAs. Proc Natl Acad Sci USA 2001;98:12620-12623.
55. Stohl W, Elliott JE, Linsley PS: Human T cell-dependent B cell differentiation induced by staphylococcal superantigens. J Immunol 1994;153:117-127.
56. Lester MR, Hofer MF, Renz H, Trumble AE, Gelfand EW, Leung DYM: Modulatory effects of staphylococcal superantigen TSST-1 on IgE synthesis in atopic dermatitis. Clin Immunol Immunopathol 1995;77:332-328.
57. Hofer MF, Newell K, Duke RC, Schlievert PM, Freed JH, Leung DYM: Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis. Proc Natl Acad Sci USA 1996;93:5425-5430.
58. Jabara HH, Geha RS: The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching. Int Immunol 1996;8:1503-1510.
59. Hofer MF, Harbeck RJ, Schlievert PM, Leung DYM: Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 1999;112:171-176.
60. Zhang K, Mills FC, Saxon A: Switch circles from IL-4-directed class switching from human B lymphocytes. Evidence for direct, sequential and multiple step sequential switch from b to Ig heavy chain gene. J Immunol 1994;152:3427-3435.
61. Zhang K, Cheah H-K, Saxon A: Secondary deletional recombination of rearranged switch region in Ig isotype-switched B cells. A mechanism for isotype stabilization. J Immunol 1995;154:2237-2247.
62. Fear DJ, McCloskey N, O'Connor B, Felsenfeld G, Gould HJ: Transcription of Ig germline genes in single human B cells and the role of cytokines in isotype determination. J Immunol 2004;173: 4529-4538.
63. Tumang JR, Cherniack EP, Gietl DM, Cole BC, Russ C, Crow MK, Friedman SM: T helper celldependent, microbial superantigen-induced murine cell activation: Polyclonal and antigenspecific antibody responses. J Immunol 1991;147:432-438.
64. Lim PL, Zouali M: PatEogenic autoantibodies: emerging insights into tissue injury. Immunol Lett 2006;103:17-26.
65. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O: Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:27-33.
66. Skov L, Olsen JV, Giorno R, Schlievert PM, Baadsgaard O, Leung DY: Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by superantigenmediated mechanism. J Allergy Clin Immunol 2000;105:820-826.
67. Laouini D, Kawamoto S, Yalcindag A, Bryce P, Mizoguchi E, Oettgen H, Geha RS: Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol 2003; 112:981-987.
68. Savinko T, Lauerma A, Lehtimaki S, Gombert M, Majuri M-L, Fyhrquist-Vanni N, Dieu-Nosjean M-C, Kemeny L, Wolff H, Homey B, Alenius H: Topical superantigen exposure induces epidermal accumulation of CD8+ T cells, a mixed Th1/Th2-type dermatitis and vigorous production of IgE antibodies in the murine model of atopic dermatitis. J Immunol 2005;175:8320-8326.
69. Herz U, Ruckert R, Wollenhaupt K, Tschernig T, Neuhaus-Steinmetz U, Pabst R, Renz H: Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness - a model for non-allergic asthma. Eur J Immunol 1999;29:1021-1031.
70. Wegmann M, Fehrenbach H, Fehrenbach A, Held T, Schramm C, Garn H, Renz H: Involvement of distal airways in a chronic model of experimental asthma. Clin Exp Allergy 2005;35:1263-1271.
71. Helling PW, Hens G, Meyts I, Bullens D, Vanoirbeek J, Gevaert P, Jorissen M, Ceuppens JL, Bachert C: Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphyloccus aureus enterotoxin B. Clin Exp Allergy 2006;36:1063-1073.
72. Leung DYM, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, Hanifin JM, Sampson HA: Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens. J Clin Invest 1993;92:1374-1380.
73. Ou L-S, Goleva E, Hall C, Leung DYM: T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004;113:756-763.
74. Goleva E, Li L-B, Eves PT, Strand MJ, Martin RJ, Leung DYM: Increased glucocorticoid receptor β alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 2006; 173:607-616.
75. Chan MT, Leung DY, Szefler SJ, Spahn JD: Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol 1998;101:594-601.
76. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, et al: Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-418.
77. Leung DY, Bloom JW: Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003;111:3-22.
78. Corrigan CJ, Kay AB: CD4 T lymphocyte activation in acute severe asthma. Int Arch Allergy Appl Immunol 1991;94:270-271.
79. Walker C, Kaegi MK, Braun P, Blaser K: Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-942.
80. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai J-J, Frew AJ, Kay AB: Glucocorticoid resistance in chronic asthma: Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991;144:1016-1025.
81. Alvarez J, Surs W, Leung DYM, Ikle D, Gelfand EW, Szefler SJ: Steroid-resistant asthma: Immunologic and pharmacologic features. J Allergy Clin Immunol 1992;89:714-721.
82. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai J-J, Frew AJ, Kay AB: Glucocorticoid resistance in chronic asthma: Peripheral blood T-lymphocyte activation and a comparison of the T-lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991;144: 1026-1032.
83. Sher ER, Leung DYM, Surs W, Kam JC, Zieg G, Kamada AK, Szefler SJ: Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994;93:33-39.
84. Kam J, Szefler SJ, Surs W, Sher E, Leung DYM: Combinations of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993;151: 3460-3466.
85. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q: Dysregulation of interleukin 6, interleukin 5 and interferon gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.
86. Adcock I, Lane S, Brown C, Peters M, Lee T, Barnes P: Differences in binding of glucocorticoid receptors to DNA in steroid resistant asthma. J Immunol 1995;154:3500-3505.
87. Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP, Klemm DJ: Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor g. J Exp Med 1997;186:1567-1574.
88. Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH: Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol 2000;105:943-950.
89. Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, Chrousos GP: Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 1999;59:1600-1604.
90. Christodoulopoulos P, Leung DYM, Elliott MW, Hogg JC, Muro S, Toda M, Laberge S, Hamid QA: Increased number of glucocorticoid receptor-β-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol 2000;106:479-484.
91. Oakley RH, Sar M, Cidlowski JA: The human glucocorticoid receptor β isoform: Expression, biochemical properties and putative function. J Biol Chem 1996;271:9550-9559.
92. Lu NZ, Cidlowski JA: Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 2005;18:331-342.
93. Lu NZ, Cidlowski JA: The origins and functions of multiple human glucocorticoid receptor isoforms. Ann NY Acad Sci 2004;1024:102-123.
94. Pratt WB, Morishima Y, Murphy M, Harrell M: Chaperoning of glucocorticoid receptors. Handb Exp Pharmacol 2006;172:111-138.
95. Schaaf MJ, Cidlowski JA: Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002;83:37-48.
96. Hauk PJ, Wenzel SE, Trumble AE, Szefler SJ, Leung DY: Increased T-cell receptor vβ8 T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: A potential role for microbial superantigens. J Allergy Clin Immunol 1999;104:37-45.
97. Li L-B, Goleva E, Hall CF, Ou L-S, Leung DYM: Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol 2004;114:1059-1069.
98. Hauk PJ, Hamid QA, Chrousos GP, Leung DY: Induction of corticosteroid insensitivity in human peripheral blood mononuclear cells by microbial superantigen. J Allergy Clin Immunol 2000;105: 782-787.
99. Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DYM, Hamid QA: Microbial superantigens induce glucocorticoid receptor β and steroid resistance in a nasal explant model. Laryngoscope 2004;114:887-892.
100. Durham SR, Gould HJ, Hamid QA: IgE regulation in tissues; in Vercelli D (ed): IgE Regulation: Molecular Mechanisms. Chichester, Wiley, 1997, pp 21-33.
101. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C: Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997;99;1492-1499.
102. Pawankar R, Yamagishi S, Yagi T: Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol 2000;14:309-317.
103. Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S, Lowhagen O, Schotman E, Cameron L, Hamid QA: Expression of ε germline gene transcripts and mRNA for the ε heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27: 2899-2906.
104. Cameron LA, Durham SR, Jacobson MR, Masuyama K, Juliusson S, Gould HJ, Masuyama K, Juliusson S, Gould HJ: Expression of IL-4, Cepsilon and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids. J Allergy Cin Immunol 1998;101: 330-336.
105. Cameron L, Hamid Q, Wright E, Nakamura Y, Christodoulopoulos P, Muro S, Frenkiel S, Lavigne F, Durham S, Gould H: Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J Allergy Clin Immunol 2000;106: 46-52.
106. Ying S, Humbert M, Menz Q, Pfister R, Menz G, Gould HJ, Kay AB, Durham SR: Local expression of ε germline gene transcripts and RNA for the ε heavy chain of IgE in the bronchial mucosa in atopic and non-atopic asthma. J Allergy Clin Immunol 2001;107:686-692.
107. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR, Kay AB: The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences. Immunol Today 1999;20:528-533.
108. Cameron L, Gounni AS, Frenkiel S, Lavigne F, Vercelli D, Hamid Q: SεSμ and SεSγ switch circles in human nasal mucosa following ex vivo allergen challenge: Evidence for direct as well as sequential class switch recombination. J Immunol 2003;171:3816-3822.
109. Takhar P, Smurthwaite L, Coker HA, Fear DJ, Banfield GK, Carr VA, Durham SR, Gould HJ: Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol 2005;174: 5024-5032.
110. Fiset PO, Cameron L, Hamid Q: Local isotype switching to IgE in airway mucosa. J Allergy Clin Immunol 2005;116:233-236.
111. Kleinjan A, Vinke JG, Severijnen LW, Fokkens WJ: Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000;15: 491-497.
112. King CL, Thyphronitis G, Nutman TB: Enumeration of IgE secreting B cells: A filter spot-ELISA. J Immunol Methods 1990;132:37-43.
113. Smurthwaite L, Walker SN, Wilson DR, Birch DS, Merrett TG, Durham SR, Gould HJ: Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol 2001;31:3422-3431.
114. Snow RE, Djukanovic R, Stevenson FK: Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patients confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology 1999;98:646-651.
115. Snow RE, Chapman CJ, Frew AF, Holgate ST, Stevenson FK: Analysis of Ig VH region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma. J Immunol 1995;154: 5576-5581.
116. Snow RE, Chapman CJ, Frew AJ, Holgate ST, Stevenson FK: Pattern of usage and somatic hypermutation in the VH5 gene segments of a patient with asthma: Implications for IgE. Eur J Immunol 1997;27:162-170.
117. Snow RE, Chapman CJ, Holgate ST, Stevenson FK: Clonally related IgE and IgG4 transcripts in blood lymphocytes of patients with asthma reveal differing patterns of somatic mutation. Eur J Immunol 1998;28:3354-3361.
118. Coker HA, Harries HE, Banfield GK, Carr VA, Durham SR, Chevretton E, Hobby P, Sutton BJ, Gould HJ: Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis. J Allergy Clin Immunol 2005;116:445-452.
119. Van der Stoep N, Van der Linden J, Logtenberg T: Molecular evolution of the human immunoglobulin E response: High incidence of shared mutations and clonal relatedness among ε VH5 transcripts from three unrelated patients with atopic dermatitis. J Exp Med 1993;177:99-107.